Search research articles
Contact Us
Filters
Showing results (511-520 of 556) with videos related to
Page
of 56
Sort By:
Clinical and Molecular Hepatology
|
May 7, 2024
Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study
Seogsong Jeong, Yun Hwan Oh, Joseph C Ahn, et al.
Contemporary Clinical Trials Communications
|
June 10, 2025
Detection of Undiagnosed Liver Cirrhosis via Artificial Intelligence-Enabled Electrocardiogram (DULCE): Rationale and design of a pragmatic cluster randomized clinical trial
Amy Olofson, Ryan Lennon, Blake Kassmeyer, et al.
British Journal of Cancer
|
June 27, 2007
A single institutional experience of thymic epithelial tumours over 11 years: clinical features and outcome and implications for future management
H-S Lee, S T Kim, J Lee, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
January 1, 1996
Delayed primary repair of intrathoracic esophageal perforation: is it safe?
N Wang, A J Razzouk, A Safavi, et al.
Contemporary Clinical Trials
|
October 3, 2012
A systems biology approach to studying Tai Chi, physiological complexity and healthy aging: design and rationale of a pragmatic randomized controlled trial
Peter M Wayne, Brad Manor, Vera Novak, et al.
Hepatology (Baltimore, Md.)
|
April 16, 2022
Racial and ethnic disparities in early treatment with immunotherapy for advanced HCC in the United States
Joseph C Ahn, Marie Lauzon, Michael Luu, et al.
Scientific Reports
|
February 7, 2024
Associations of cholecystectomy with metabolic health changes and incident cardiovascular disease: a retrospective cohort study
Sangwoo Park, Seogsong Jeong, Sun Jae Park, et al.
Transplantation Proceedings
|
December 20, 2000
Efficacy of tacrolimus in primary kidney transplant patients: multicenter, open-label prospective study
K Park, C Ahn, B K Bang, et al.
ESMO Open
|
February 14, 2022
Adjuvant durvalumab for esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy: a placebo-controlled, randomized, double-blind, phase II study
S Park, J-M Sun, Y-L Choi, et al.
Acta Oncologica (Stockholm, Sweden)
|
October 24, 2001
Preoperative concurrent chemoradiotherapy for stage IIIA non-small cell lung cancer
Y C Ahn, K Park, D Y Kim, et al.
Page
of 56
Search research articles
Search
Showing results (511-520 of 556) with videos related to
Sort By:
Page
of 56
Clinical and Molecular Hepatology
|
May 7, 2024
Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study
Seogsong Jeong, Yun Hwan Oh, Joseph C Ahn, et al.
Contemporary Clinical Trials Communications
|
June 10, 2025
Detection of Undiagnosed Liver Cirrhosis via Artificial Intelligence-Enabled Electrocardiogram (DULCE): Rationale and design of a pragmatic cluster randomized clinical trial
Amy Olofson, Ryan Lennon, Blake Kassmeyer, et al.
British Journal of Cancer
|
June 27, 2007
A single institutional experience of thymic epithelial tumours over 11 years: clinical features and outcome and implications for future management
H-S Lee, S T Kim, J Lee, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
January 1, 1996
Delayed primary repair of intrathoracic esophageal perforation: is it safe?
N Wang, A J Razzouk, A Safavi, et al.
Contemporary Clinical Trials
|
October 3, 2012
A systems biology approach to studying Tai Chi, physiological complexity and healthy aging: design and rationale of a pragmatic randomized controlled trial
Peter M Wayne, Brad Manor, Vera Novak, et al.
Hepatology (Baltimore, Md.)
|
April 16, 2022
Racial and ethnic disparities in early treatment with immunotherapy for advanced HCC in the United States
Joseph C Ahn, Marie Lauzon, Michael Luu, et al.
Scientific Reports
|
February 7, 2024
Associations of cholecystectomy with metabolic health changes and incident cardiovascular disease: a retrospective cohort study
Sangwoo Park, Seogsong Jeong, Sun Jae Park, et al.
Transplantation Proceedings
|
December 20, 2000
Efficacy of tacrolimus in primary kidney transplant patients: multicenter, open-label prospective study
K Park, C Ahn, B K Bang, et al.
ESMO Open
|
February 14, 2022
Adjuvant durvalumab for esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy: a placebo-controlled, randomized, double-blind, phase II study
S Park, J-M Sun, Y-L Choi, et al.
Acta Oncologica (Stockholm, Sweden)
|
October 24, 2001
Preoperative concurrent chemoradiotherapy for stage IIIA non-small cell lung cancer
Y C Ahn, K Park, D Y Kim, et al.
Page
of 56